J. Beck

发表

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

H. Einsele, L. Kanz, C. Niemeyer, 1998, Bone Marrow Transplantation.

Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study.

B. Hero, H. Jürgens, T. Klingebiel, 1998, European journal of cancer.

Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry.

G. Seitz, T. Klingebiel, R. Handgretinger, 1997, European journal of cancer.

Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cells.

Bernd Bohnet, J. Dietl, R. Scheper, 1998, Anticancer research.

Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.

G. Seitz, V. Gekeler, H. Lode, 1995, European journal of cancer.

Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML.

T. Klingebiel, G. Ehninger, R. Handgretinger, 1996, Leukemia.

Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin.

D. V. von Schweinitz, J. Fuchs, P. Bader, 1998, Anticancer research.

Suicide genes: past, present and future perspectives.

U. Lauer, D. Niethammer, J. Beck, 2000, Immunology today.

MDR1, MRP, topoisomerase IIalpha/beta, and cyclin A gene expression in acute and chronic leukemias.

V. Gekeler, D. Niethammer, J. Beck, 1996, Leukemia.

Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin

T. Klingebiel, R. Handgretinger, P. Bader, 1998, Annals of Hematology.

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

T. Klingebiel, R. Handgretinger, P. Bader, 1999, Leukemia.

Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.

R. Handgretinger, V. Gekeler, D. Niethammer, 1996, Cancer letters.

High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.

V. Gekeler, D. Niethammer, J. Beck, 1994, Cancer letters.

Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse?

T. Klingebiel, R. Handgretinger, P. Bader, 1997, Bone Marrow Transplantation.

Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias

G. Ehninger, R. Handgretinger, V. Gekeler, 2005, Annals of Hematology.

Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL

T. Klingebiel, J. Hancock, R. Handgretinger, 2002, Leukemia.

Characterization of lineage‐specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse

H. Einsele, C. Niemeyer, T. Klingebiel, 2000, British journal of haematology.

Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children

T. Klingebiel, R. Handgretinger, P. Bader, 1997, Bone Marrow Transplantation.

Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia.

K. Klingel, T. Klingebiel, G. Ehninger, 1995, Bone marrow transplantation.

Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT.

T. Klingebiel, R. Handgretinger, P. Bader, 1996, Anticancer research.

Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts.

H. Einsele, G. Seitz, T. Orlikowsky, 1999, Leukemia research.

Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.

Bernd Bohnet, R. Kandolf, J. Dietl, 1998, British Journal of Cancer.

Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias.

T. Klingebiel, R. Handgretinger, V. Gekeler, 1995, British journal of haematology.

Methods for the Determination of the Interferon-Induced Enzyme 2'-5' Oligoadenylate Synthetase in Mononuclear Blood Cells

D. Niethammer, J. Beck, G. Bruchelt, 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Expression analysis of multidrug resistance associated genes in neuroblastomas.

T. Klingebiel, R. Girgert, R. Handgretinger, 1999, Oncology reports.

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective

D. Reinhardt, C. Niemeyer, T. Klingebiel, 2004, Bone Marrow Transplantation.